Scientist, Vertex: Led the Hepatitis-C program to commercialization and introduced industry-transforming continuous manufacturing methods.
VP BD & CMC and Co-Founder, Trek Therapeutics: Secured six in-licensed assets with minimal upfront costs and initiated clinical trials within the company’s first year.
VP Technical Operations and QA, Living Proof: Streamlined manufacturing processes, achieving an efficiency leap from 2 sigma to 5 sigma.